Announce topline data from Phase 1 trials for SION-719 and SION-451
Delivered by the deadline
AI-confirmed · human review in progress Independent AI checks agreed on primary SEC or regulator evidence. Records are now being reviewed by hand, starting with those our customers order.
- Announced
- 20 Mar 2025
- Due
- 30 Jun 2025
- Delivered
- June 2025
- Deadline
- Met
- Late
- Not met
- Today
What the company said
“Topline data from both trials are expected in the first half of 2025.”
What we found
Evidence strength A What the grades mean
The company announced positive topline data from the Phase 1 trials for both SION-719 and SION-451 in June 2025, meeting the commitment to provide these results within the first half of 2025.
-
A Sionna Therapeutics, Inc. 10-Q filed 2025-08-11
“In June 2025, we announced positive topline data from our two randomized, double-blinded, placebo-controlled Phase 1 clinical trials evaluating SION-719 and SION-451” ✓ confirmed on the page
Market reaction: the shares moved +17.1% against the S&P 500 over the three sessions around the disclosure (8 Aug 2025 to 13 Aug 2025). What this measures
Checked 1 Oct 2026.
Commitment DNA
The structured record of this commitment. Fields the company did not state are left blank rather than guessed.
- Event type
- Clinical readout
- Indicative materiality
- Medium rules
- Action
- Announce
- Deliverable
- Phase 1 topline data
- Language
- Expected (“expects”, “plans”)
- In the company’s control
- High
- Specificity
- High
How this entry was checked
- Commitment recordedThe company's words were matched word for word against the filing.
- First checkAn AI model, Gemini (Google), read the company's later filings and recorded the outcome with a quoted passage.
- Second check: agreesA different AI model, Claude (Anthropic), re-read the evidence without being told the outcome and reached the same answer.
Confirmed. This outcome counts towards the company's Kept Score. How verification works
Are you Sionna Therapeutics, Inc.? You can publish an official statement next to this entry, free. Add a statement.
Is something here wrong or out of date? Companies and readers can ask us to check it. Please bring a link to a public source.
Report an error in this entry Reference: KI-C-2025-SION-001948 · Corrections policy